8th Sep 2008 14:00
Issued: Monday 8 September 2008, London UK
GlaxoSmithKline plc - Directorate change
GlaxoSmithKline plc (GSK) today announced that Chris Viehbacher, Executive Director and President North American Pharmaceuticals, has decided to stand down from the Board on 8th September, and will leave the company with effect from 1st December 2008 to pursue another opportunity.
Andrew Witty, Chief Executive Officer said: I would like to thank Chris for his significant contribution to GSK, he is one of the most talented and respected executives in this industry and we wish him well in his future endeavours."
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com
|
Enquiries: |
||
|
UK Media enquiries: |
Philip Thomson |
(020) 8047 5502 |
|
Claire Brough |
(020) 8047 5502 |
|
|
Alice Hunt |
(020) 8047 5502 |
|
|
Gwenan White |
(020) 8047 5502 |
|
|
US Media enquiries: |
Nancy Pekarek |
(215) 751 7709 |
|
Mary Anne Rhyne |
(919) 483 2839 |
|
|
Sarah Alspach |
(215) 751 7709 |
|
|
European Analyst/Investor enquiries: |
David Mawdsley |
(020) 8047 5564 |
|
Sally Ferguson |
(020) 8047 5543 |
|
|
Gary Davies |
(020) 8047 5503 |
|
|
US Analyst/ Investor enquiries: |
Frank Murdolo |
(215) 751 7002 |
|
Tom Curry |
(215) 751 5419 |
|
Cautionary statement regarding forward-looking statementsUnder the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2007. |
|
Registered in England & Wales: No. 3888792 |
|
Registered Office: 980 Great West Road Brentford, Middlesex TW8 9GS |
Related Shares:
Glaxosmithkline